Existing Account?

For general enquiries, please contact Ms. Joy Chang
+886-2-2798-8329 Ext. 48 mbi2022@elitepco.com.tw

Scientific Programme

The symposium will comprise of excellent scientific programme on Oct. 29-30, including (1) keynote speeches from influential scientists worldwide, (2) PNIRSAsia-Pacific Sponsored Symposium, (3) state of the art symposia, and presentations from researchers and clinicians, (4) lectures of psychiatric researches and (5) virtual poster sessions. The symposium venue is to be announced.

 

 Programme Overview (Tentaive)  Updated on Sep. 15

 

 Programme Details 

PK1. Plenary Keynote 1

Yeon-Ray Wen, MD., PhD. Neuromodulation in Chronic Pain Management: Not Only Modulate Pain, but Also Body And Mind 


PK2. Plenary Keynote 2

David Mischoulon, MD., PhD. | Placebo Effects: Blessing and Curse


PK3. Plenary Keynote 3

Neil Harrison, PhD. | Inflammation-induced sickness and depression: Insights from human experimental challenge studies


S11. The Impacts of COVID-19 Pandemic Session

  • Kuan-Pin Su, MD, PhD (Chair) | Nutritional medicine in the psychoneuroimmunity against long COVID
  • Marco Solmi, MD, PhD | Design of the Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT)
  • Christoph U. Correll, MD | The effect of the COVID pandemic world-wide: Initial results from the COH-FIT study
  • Esther Melamed, MD., PhD. | Long-COVID: The autoimmune dilemma in neuropsychiatric disorders

S12. PNIRS Asia-Pacific Session : Pain subtypes and the distinct and overlapping mechanisms behind them.


S13. Pain Treatment from Eastern to Western Methods Session : Pain relief from the perspective of Eastern and Western medicine

  • I-Han Hsiao MD, PhD (Chair) | Using novel techniques to investigate pain and depression 
  • Hsien-Yin Liao Ph.D., M.D. (Chair) | Clinical Efficacy and Immune Effects of Acupuncture in Patients with Comorbid Chronic Pain and Major Depression Disorder: A Double-Blinded, Randomized Controlled Crossover Study
  • Younbyoung Chae Ph.D., K.M.D. | Mind-body interaction of acupuncture actions in pain control

S21. Novel Treatment for Depression Session : Leveraging Placebo Effects and Mind-Body Phenomena in the Treatment of Depression

  •  David Mischoulon, MD, PhD (Chair)
  • Cristina Cusin, MD | Neurobiological Underpinnings of Placebo Response in Major Depressive Disorder:  Methodology of a biomarker study using PET/MRI 
  • Lauren Fisher, PhD | Feasibility and Acceptability of Adapted Cognitive Behavioral Therapy for Depression after Traumatic Brain Injury
  • Felipe Jain, MD | Impact of Mentalizing Imagery Therapy on family dementia caregivers with suicidal ideation: feasibility and diffusion tensor imaging measures
  • Albert Yeung, Md, ScD An introduction to Ketamine Assisted Psychotherapy (KAP) 

S22. ISNPR Nutritional Psychiatry Session : Nutrition in Mental Health: Current Trends and Updates

  • Wolfgang Marx, PhD (Chair) | Nutrition in Mental Health: Current Trends and Updates
  • Annabel S. Mueller-Stierlin, PhD | Subjective implications of dietary intake and eating behaviours for people with serious mental illness
  • Jane Chang, MD, PhD | Omega-3 PUFAs in Children and Adolescents: Focused on ADHD, ASD and Depression
  • Angela Sherwin, BSc | HAPI Trial – High Anxiety Pyrrole Intervention Trial
  • Calogero Longhitano, MD | Rationale for the use of Ketogenic diet and in Bipolar Affective Disorder and Schizophrenia: the current clinical evidence and a proposed RCT.
  • Tae Kim, MD, PhD | Vitamin D plays a key role in the transcriptional regulation of amyloidopathy and gliopathy in Alzheimer's disease

S23. ISNPR IIEffects of Ketogenic Diet Therapy Session : From Mice to Men, from Migraines to Psychosis. How ketosis hacks the brain’s bioenergetic metabolism to restore healthy neural function.

  • Calogero Longhitano, PhD (Chair) | Nutritional interventions in psychosis review. A brief history of dietary interventions in severe mental disorders and how a low-carb high-fat diet can act as a powerful metabolic enhancer of brain cell function. 
  • Zoltan Sarnyai, PhD | From Mice to Men. Effects of ketogenic diet on behavioural models of psychiatry and why the effect might be translatable to humans. 
  • Christopher Palmer, MD | Ketogenic Diet in psychosis, mitochondrial health and a new paradigm to explain mental disorders